Cargando…
A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2
Hepatocellular carcinoma (HCC) that is triggered by metabolic defects is one of the most malignant liver cancers. A much higher incidence of HCC among men than women suggests the protective roles of estrogen in HCC development and progression. To begin to understand the mechanisms involving estrogen...
Autores principales: | Shen, Minqian, Xu, Mengyang, Zhong, Fanyi, Crist, McKenzie C., Prior, Anjali B., Yang, Kundi, Allaire, Danielle M., Choueiry, Fouad, Zhu, Jiangjiang, Shi, Haifei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924215/ https://www.ncbi.nlm.nih.gov/pubmed/33672651 http://dx.doi.org/10.3390/cells10020455 |
Ejemplares similares
-
Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
por: Shen, Minqian, et al.
Publicado: (2016) -
Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing
por: Shen, Minqian, et al.
Publicado: (2018) -
Molecular Mechanisms behind Safranal’s Toxicity to HepG2 Cells from Dual Omics
por: Nelson, David Roy, et al.
Publicado: (2022) -
Artificial cells eavesdropping on HepG2 cells
por: Westensee, Isabella Nymann, et al.
Publicado: (2023) -
Anti-tumor effect of volatile oil from Houttuynia cordata Thunb. on HepG2 cells and HepG2 tumor-bearing mice
por: Yang, Linsong, et al.
Publicado: (2019)